Related Experiment Video
Updated: May 9, 2026

07:37
Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model
Published on: January 26, 2024
Photoreceptor-like cells in transgenic mouse eye
Run-Tao Yan1, Xiumei Li, Shu-Zhen Wang
1Department of Ophthalmology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 35294-0019, USA. rtyan@uab.edu
Investigative Ophthalmology & Visual Science
|July 13, 2013
Summary
Researchers reprogrammed retinal pigment epithelium (RPE) cells into photoreceptor-like cells in adult mice. This offers a potential new strategy for generating cells for vision restoration therapies.
Area of Science:
- Ophthalmology
- Developmental Biology
- Cell Biology
Background:
- Photoreceptor degeneration leads to vision loss.
- Successful vision rescue in mouse models highlights the need for photoreceptor replacement strategies.
- Generating photoreceptor cells is crucial for future cell-based therapies.
Purpose of the Study:
- To investigate if retinal pigment epithelium (RPE) cells can be experimentally reprogrammed into photoreceptor-like cells in the adult mouse eye.
- To explore the potential of using regulatory genes to induce RPE-to-photoreceptor cell fate conversion.
Main Methods:
- Generation of transgenic mice expressing neurogenin1 or neurogenin3 under RPE-specific promoters.
- Histological and immunohistological analysis of transgenic mouse eyes to identify photoreceptor-like cells and transitional cell stages.
- Explant culture of RPE-containing eyecups to assess de novo photoreceptor generation.
Main Results:
- Transgenic mice developed photoreceptor-like cells expressing key photoreceptor proteins (recoverin, red opsin, rhodopsin) in the subretinal space.
- Evidence of RPE-to-photoreceptor cell transformation was observed in both young and aged mice.
- De novo generation of photoreceptor-like cells was confirmed in eyecup explants from adult animals.
Conclusions:
- Experimental reprogramming of RPE cells can generate photoreceptor-like cells in situ within the adult mammalian eye.
- This approach presents a promising avenue for developing novel cell-based therapies for retinal degenerative diseases.

